Huang Y - Search Results

1

Mechanism underlying the immune checkpoint inhibitor-induced hyper-progressive state of cancer.

Ding P, Wen L, Tong F, Zhang R, Huang Y, Dong X. Ding P, et al. Among authors: huang y. Cancer Drug Resist. 2022 Feb 8;5(1):147-164. doi: 10.20517/cdr.2021.104. eCollection 2022. Cancer Drug Resist. 2022. PMID: 35582541 Free PMC article. Review.

2

Programmed cell death 1 inhibitors with or without concurrent brain radiotherapy for lung cancer patients with brain metastases.

Huang Y, Li H, Peng L, Tong F, Wen L, Zhang R, Cheng S, Dong X. Huang Y, et al. Ann Palliat Med. 2021 Sep;10(9):9974-9983. doi: 10.21037/apm-21-2334. Ann Palliat Med. 2021. PMID: 34628921 Free article.

3

The Research Progress of PD-1/PD-L1 Inhibitors Enhancing Radiotherapy Efficacy.

Wen L, Tong F, Zhang R, Chen L, Huang Y, Dong X. Wen L, et al. Among authors: huang y. Front Oncol. 2021 Dec 9;11:799957. doi: 10.3389/fonc.2021.799957. eCollection 2021. Front Oncol. 2021. PMID: 34956911 Free PMC article. Review.

4

The influence of pemetrexed-based continuous maintenance therapy on survival of locally advanced and metastatic lung adenocarcinoma.

Huang Y, Wang Y, Hu D, Chen L, Zhang R, Cheng S, Wu G, Dong X. Huang Y, et al. Ann Transl Med. 2019 Oct;7(20):524. doi: 10.21037/atm.2019.10.15. Ann Transl Med. 2019. PMID: 31807506 Free PMC article.

5

Single-cell RNA-Seq reveals the potential risk of anti-mesothelin CAR T Cell therapy toxicity to different organs in humans.

Wen L, Huang Y, Peng L, Zhao K, Sun Y, Lin Z, Chen Y, Li Z, Qian Q, Tong F, Zhang R, Dong X. Wen L, et al. Among authors: huang y. Front Immunol. 2022 Aug 17;13:807915. doi: 10.3389/fimmu.2022.807915. eCollection 2022. Front Immunol. 2022. PMID: 36059490 Free PMC article.

6

Efficacy and safety of recombinant human endostatin combined with whole-brain radiation therapy in patients with brain metastases from non-small cell lung cancer.

Chen L, Tong F, Peng L, Huang Y, Yin P, Feng Y, Cheng S, Wang J, Dong X. Chen L, et al. Among authors: huang y. Radiother Oncol. 2022 Sep;174:44-51. doi: 10.1016/j.radonc.2022.06.022. Epub 2022 Jul 3. Radiother Oncol. 2022. PMID: 35788355 Clinical Trial.

7

Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study.

Yang K, Sheng Y, Huang C, Jin Y, Xiong N, Jiang K, Lu H, Liu J, Yang J, Dong Y, Pan D, Shu C, Li J, Wei J, Huang Y, Peng L, Wu M, Zhang R, Wu B, Li Y, Cai L, Li G, Zhang T, Wu G. Yang K, et al. Among authors: huang c, huang y. Lancet Oncol. 2020 Jul;21(7):904-913. doi: 10.1016/S1470-2045(20)30310-7. Epub 2020 May 29. Lancet Oncol. 2020. PMID: 32479787 Free PMC article.

8

Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer.

Ai B, Liu H, Huang Y, Peng P. Ai B, et al. Among authors: huang y. Oncotarget. 2016 Jul 12;7(28):44583-44595. doi: 10.18632/oncotarget.10069. Oncotarget. 2016. PMID: 27323821 Free PMC article.

9

A dual mTORC1 and mTORC2 inhibitor shows antitumor activity in esophageal squamous cell carcinoma cells and sensitizes them to cisplatin.

Huang Y, Xi Q, Chen Y, Wang J, Peng P, Xia S, Yu S. Huang Y, et al. Anticancer Drugs. 2013 Oct;24(9):889-98. doi: 10.1097/CAD.0b013e328363c64e. Anticancer Drugs. 2013. PMID: 23838676

10

Combined treatment with PI3K inhibitor BKM120 and PARP inhibitor olaparib is effective in inhibiting the gastric cancer cells with ARID1A deficiency.

Yang L, Yang G, Ding Y, Huang Y, Liu S, Zhou L, Wei W, Wang J, Hu G. Yang L, et al. Among authors: huang y. Oncol Rep. 2018 Jul;40(1):479-487. doi: 10.3892/or.2018.6445. Epub 2018 May 16. Oncol Rep. 2018. PMID: 29767248

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80,901 results

Search Page

Filters